- Exchange: Canadian Sec
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Arch Biopartners Inc+ Add to Watchlist
ACH:CN0.3500 CAD 0.0500 16.67%
As of 13:19:29 ET on 12/17/2014.
Company Profile for Arch Biopartners Inc (ACH)
Arch Biopartners Inc. is a biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies. The Company is focused on treatments for brain tumours, chronic kidney and bowel diseases caused by non-infectious inflammation, and binding of peptides to solid surfaces.
Arch Biopartners Inc
Key Executives for Arch Biopartners Inc (ACH)
|Richard G MuruvePresident/CEO||Daniel Abraham MuruveChief Science Officer|